Quarterly report pursuant to Section 13 or 15(d)

Stockholders Equity and StockBased Compensation (Details 2)

v3.21.1
Stockholders Equity and StockBased Compensation (Details 2)
3 Months Ended
Mar. 31, 2021
$ / shares
shares
Number of options  
Options outstanding, Beginning of the period | shares 515,847
Options outstanding, Granted | shares 0
Options outstanding, Exercised | shares 0
Options outstanding, Forfeited | shares 0
Options outstanding, Expired | shares (711)
Options outstanding, End of the period | shares 515,136
Options outstanding, options exercisable | shares 465,410
Weighted Average Exercise Price  
Weighted Average Exercise Price Beginning of the period $ 20.23
Weighted Average Exercise Price Stock Options Granted 0
Weighted Average Exercise Price Stock Options Exercised 0
Weighted Average Exercise Price Stock Options Forfeited 0
Weighted Average Exercise Price Stock Options Expired 331.80
Weighted Average Exercise Price End of the year 19.80
Weighted Average Exercise Price Options exercisable 20.88
Weighted Average Grant Date Fair Value  
Weighted Average Fair Value Stock Options Beginning of the period 14.51
Weighted Average Fair Value Stock Options Granted 0
Weighted Average Fair Value Stock Options Exercised 0
Weighted Average Fair Value Stock Options Forfeited 0
Weighted Average Fair Value Stock Options Expired 293.39
Weighted Average Fair Value Stock Options End of the year 14.13
Weighted Average Fair Value Options exercisable $ 14.84